WANG HUIMIN 4
4 · Edwards Lifesciences Corp · Filed Apr 8, 2022
Insider Transaction Report
Form 4
WANG HUIMIN
CVP, Japan & Intercontinental
Transactions
- Exercise/Conversion
Common Stock
2022-04-08$35.20/sh+3,675$129,348→ 101,898.802 total - Sale
Common Stock
2022-04-08$123.07/sh−3,675$452,282→ 98,223.802 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2022-04-08−3,675→ 36,750 totalExercise: $35.20From: 2016-06-12Exp: 2023-05-11→ Common Stock (3,675 underlying)
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022.